Medical Innovation

Medical Innovation

Americans today are benefiting from medical developments and discoveries that took shape almost two decades ago. On average, the travel time of an experimental drug from the lab to patients is 12 to15 years. Lawmakers need to realize the considerable impact that federal policies can have on maintaining the future of drug discovery and innovation.

All Americans, especially the aging, want the best therapies for life-threatening diseases and disabling and chronic conditions. A core goal of the Alliance for Aging Research is to encourage policies which will lead to newer and better treatments to improve the health and independence of Americans as they age.

Related Publications

    • Press Release
      Growing Burden of Persistent Pain Calls for More Medical Innovation
      February 20, 2013
      Related topics: Access to Breakthroughs    Aging Research  Cancer  Federal Funding  Health  Medical Innovation  Persistent Pain  Policy  Research  

                                                                                                                                        Cynthia Bens, Alliance for Aging Research

                                                                                                                                                      cbens@agingresearch.org, 202-293-2856
                                                                                                                                                      Penney Cowan, American Chronic Pain Assoc.

                                                                                                                                                      pcowan@tehacpa.org, 916-632-0922

                                                                                                                                                      Nicole Grady, American Osteopathic Assoc.

                                                                                                                                                      ngrady@osteopathic.org, 312-202-8038

                                                                                                                                                      Paul Gileno, US Pain Foundation

                                                                                                                                        uspainfoundation@gmail.com, 860-788-6062


      Washington, D.C.  – Today, the Alliance for Aging Research released a new volume of The Silver Book®: Chronic Disease and Medical Innovation in an Aging Nation.  This latest addition to The Silver Book series paints a comprehensive picture of the burden of persistent pain, and the value of innovation that helps reduce that burden.  The briefing--held in partnership with the American Chronic Pain Association, the American Osteopathic Association, and the US Pain Foundation--featured a medical expert, a pain patient, and leaders from the partnering organizations.



    • Feature Article
      The Month of Love and Heart Health
      Winter 2013 | Alliance for Aging Reearch
      Related topics: Cardiovascular Disease  Medical Innovation  

      It’s that time of year where people throughout the world exchange candy, flowers, and sentimental gifts with their loved ones, and those that they hope to love.  While many of us believe—especially those who grumble at the thought of the lovey-dovey holiday—that Valentine’s Day was invented by greeting card and chocolate companies to up their profits, it actually has a long, and somewhat dark history.

      Heart health advocacy organizations are hoping to add to the history of Valentine’s Day by designating the month of love “heart health month” and making it another reminder of how important it is that we protect and cherish both our loved ones and our hearts.

    • Fact Sheet
      The Silver Book: Atrial Fibrillation
      February 2013 | Alliance for Aging Research
      Related topics: Aging Research  Cardiovascular Disease  Health  Medical Innovation  Policy  Prevention  Stroke  

      Atrial fibrillation impacts between 2.7 and 6.1 million adults and can lead to stroke, heart failure, dementia, disability, and death. It also costs a tremendous amount of money--at least $6.65 billion each year. This latest factsheet from The Silver Book brings the leading data on the burden of the disease and the value of innovation to reduce that burden, all into one place.

More Related Publications »

Related Media

More Related Media »